Caso de Estudo 2: Laudon, K. C. & Laudon, J. P. "Management Information Systems", Pearson Prentice Hall)
Caso de Estudo 2: Laudon, K. C. & Laudon, J. P. "Management Information Systems", Pearson Prentice Hall)
Caso de Estudo 2: Laudon, K. C. & Laudon, J. P. "Management Information Systems", Pearson Prentice Hall)
Novartis is replacing legacy systems at Novartis offices in more than 50 countries with
SAP enterprise software for human resources, supplier relationship management, and supply
chain management. Management believes the SAP software will help the company cut down
system integration costs as well as standardize and streamline administrative processes, work
flow, and reporting in its worldwide operations. The SAP software would also help the company
comply with U.S. Food and Drug Administration regulations on electronic records and
signatures for the pharmaceutical industry.
Novartis had already adopted SAPs R/3 enterprise resource planning and financial
modules for many of its operating units. Given the companys enthusiasm for enterprise systems
and SAP, it was surprising to learn that the accounts payable department at Novartis
Pharmaceuticals, the U.S. arm of the company, was having problems with its SAP enterprise
system. Somewhere in the process of paying invoices, payments were being held, and a backlog
of overdue bills was building. A few vendors even withheld credit from the company.
The accounts payable and strategic sourcing departments fingered a recent upgrade to the
SAP R/3 financial modules as the source of their financial crisis. Novartis had insisted that SAP
be its global standard and the software just wasnt working for them. In frustration, these groups
began meeting to figure out a way to redesign their requisition-to-pay process, even if it meant
scrapping SAP modules that did not meet their needs. They did not want to work with the
Novartis information systems department.
Novartiss information systems staff, on the other hand, believed the unpaid invoices were
not entirely caused by the SAP software. The companys existing process for invoicing was
inefficient, requiring manual approvals from many different managers. It was not a true
integrated requisition-to-pay process. Work was still structured into silos and no one knew what
was going on.
The information systems staff thought a recent implementation of the SAP R/3 software
would solve the problem. It believed that if it let the SAP software handle as many business
processes as possible, it would not have to deal with so many interfaces between different
information systems. The information systems department had assigned special staff members to
serve as business information managers (BIMs) who could work more closely with end user
departments to clarify and support business goals. Nevertheless, because of tight deadlines and
limited budget, information systems specialists scrimped on training and did not pay sufficient
attention to the new systems impact on business processes.
One was to create a new way for the information systems, accounts payable, and strategic
sourcing departments to work together to facilitate rapid business transformation. The other
outcome was a proposal to improve the purchasing process for Novartis departments so that they
would no longer make independent purchases. Instead, all requisitions would be channeled
through the strategic sourcing department. By centralizing purchases, the company would be
able to obtain larger discounts from suppliers because it was buying in larger quantities. About
US$4 million to $5 million could be saved annually this way.
In May 2003 the information systems department agreed to update an old system from
Ariba that would reduce late payments by automatically reconciling sourcing and accounts
payable. The Ariba upgrade improved Novartiss purchasing process so much that US$4 to $5
million in savings were achieved within six months.
Sources: Stephanie Overby, Cant We All Just Get Along? CIO Australia, March 10, 2004 and
SAP Chosen by Novartis as a Major Building Block, EETimes, June 16, 2003.
To Think About:
Why was Novartis having trouble with its requisition-to-pay process?
What management, organization, and technology factors were involved?
Was the solution to this problem a good one? Why or why not?